Protease Signaling to G Protein-Coupled Receptors: Implications for Inflammation and Pain

REFERENCES

• Southan C. A genomic perspective on human proteases. FEBS Lett 2001; 498: 214–218
   PubMed Web of Science ®Google Scholar
• Ossovskaya V S, Bunnett N W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84: 579–621
   PubMed Web of Science ®Google Scholar
• Vergnolle N. Clinical relevance of proteinase-activated receptors in the gut. Gut 2005; 54: 867–874
   PubMed Web of Science ®Google Scholar
• Dulon S, Cande C, Bunnett N W, Hollenberg M D, Chignard M, Pidard D. Proteinase-activated receptor-2 and human lung epithelial cells: Disarming by neutrophil serine proteinases. Am J Respir Cell Mol Biol 2003; 28: 339–346
   PubMedGoogle Scholar
• Dulon S, Leduc D, Cottrell G S, D'Alayer J, Hansen K K, Bunnett N W, et al. Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 2005; 32: 411–419
   PubMedGoogle Scholar
• Coughlin S R, Camerer E. Participation in inflammation. J Clin Invest 2003; 111: 25–27
   PubMed Web of Science ®Google Scholar
• Vergnolle N. The enteric nervous system in inflammation and pain: The role of proteinase-activated receptors. Can J Gastroenterol 2003; 17: 589–592
   PubMed Web of Science ®Google Scholar
• Camerer E, Huang W, Coughlin S R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000; 97: 5255–5260
   PubMed Web of Science ®Google Scholar
• Cottrell G S, Amadesi S, Grady E F, Bunnett N W. Trypsin IV: A novel agonist of protease-activated receptors 2 and 4. J Biol Chem 2004; 279: 13532–13539
   PubMed Web of Science ®Google Scholar
• Sambrano G R, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin S R, Cathepsin G. activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 6819–6823
   PubMed Web of Science ®Google Scholar
• Hollenberg M D, Compton S J. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002; 54: 203–217
   PubMed Web of Science ®Google Scholar
• Cenac N, Vergnolle N. Proteases and protease-activated receptors (PARs): Novel signals for pain. Curr Top Med Chem 2005; 5: 569–576
   PubMed Web of Science ®Google Scholar
• Asfaha S, Brussee V, Chapman K, Zochodne D W, Vergnolle N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 2002; 135: 1101–1106
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Ferazzini M, D'Andrea M R, Buddenkotte J, Steinhoff M. Proteinase-activated receptors: Novel signals for peripheral nerves. Trends Neurosci 2003b; 26: 496–500
   PubMedGoogle Scholar
• Vergnolle N, Cellars L, Chapman K. Proteinase-activated receptor-1 agonists attenuate visceral pain. Gastroenterology 2003a; 124: A–252
   Google Scholar
• Cenac N, Andrews C N, Holzhausen M, Chapman K, Cottrell G, ndrade-Gordon P, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007; 117: 636–647
   PubMed Web of Science ®Google Scholar
• Coelho A M, Vergnolle N, Guiard B, Fioramonti J, Bueno L. Proteinases and proteinase-activated receptor 2: A possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002; 122: 1035–1047
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Bunnett N W, Sharkey K A, Brussee V, Compton S, Grady E F, et al. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 2001; 7: 821–826
   PubMed Web of Science ®Google Scholar
• Nakanishi-Matsui M, Zheng Y W, Sulciner D J, Weiss E J, Ludeman M J, Coughlin S R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609–613
   PubMed Web of Science ®Google Scholar
• Asfaha S, Cenac N, Houle S, Altier C, Papez M D, Nguyen C, et al. Protease-activated receptor-4: A novel mechanism of inflammatory pain modulation. Br J Pharmacol 2007; 150: 176–185
   PubMed Web of Science ®Google Scholar
• Hollenberg M D, Saifeddine M, Sandhu S, Houle S, Vergnolle N. Proteinase-activated receptor-4: Evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol 2004; 143: 443–454
   PubMed Web of Science ®Google Scholar
• Houle S, Papez P, Ferazzini M, Hollenberg M D, Vergnolle N. (2005) Neutrophils and the kallikrein-kinin system in Proteinase-Activated Receptor 4-mediated inflammation. Br J Pharmacol 2005; 146: 670–678
   PubMed Web of Science ®Google Scholar
• Kahn M, Zheng Y, Huang C, Bigornia V, Zeng D, Moff S, et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690–694
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Derian C K, D'Andrea M R, Steinhoff M, Andrade-Gordon P. Characterization of thrombin-induced leukocyte rolling and adherence: A potential pro-inflammatory role for Proteinase-Activated Receptor-4 (PAR-4). J Immunol 2002; 169: 1467–1473
   PubMed Web of Science ®Google Scholar
• Cirino G, Cicala C, Bucci M, Sorrentino L, Maraganore J, Stone S. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 1996; 183: 821–827
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Hollenberg M D, Sharkey K, Wallace J L. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR-2)-activating peptides in the rat paw. Br J Pharmacol 1999a; 127: 1083–1090
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Hollenberg M D, Wallace J L. Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1). Br J Pharmacol 1999b; 126: 1262–1268
   PubMed Web of Science ®Google Scholar
• Ferrell W R, Lockhart J C, Kelso E B, Dunning L, Plevin R, Meek S E, et al. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 2003; 111: 35–41
   PubMed Web of Science ®Google Scholar
• Seeliger S, Derian C K, Vergnolle N, Bunnett N W, Nawroth R, Schmelz M, et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003; 17: 1871–1885
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Cellars L, Mencarelli A, Rizzo G, Swaminathan S, Beck P, et al. A role for proteinase-activated receptor-1 in inflammatory bowel diseases. J Clin Invest 2004; 114: 1444–1456
   PubMed Web of Science ®Google Scholar
• Schmidlin F, Amadesi S, Dabbagh K, Lewis D E, Knott P, Bunnett N W, et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 2002; 169: 5315–5321
   PubMed Web of Science ®Google Scholar
• Defea K A, Zalevsky J, Thoma M S, Dery O, Mullins R D, Bunnett N W. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 2000; 148: 1267–1281
   PubMed Web of Science ®Google Scholar
• Holzhausen M, Spolidorio L C, Ellen R, Jobin M, Steinhoff M, Andrade-Gordon P, et al. Host-pathogen interactions: role for Protease-Activated Receptor-2 (PAR2) activation in host response to Porphyromonas gingivalis infection. Am J Pathol 2006; 168: 1189–1199
   PubMedGoogle Scholar
• Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie E J, et al. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 1998; 435: 45–48
   PubMedGoogle Scholar
• Lourbakos A, Potempa J, Travis J, D'Andrea M R, Andrade-Gordon P, Santulli R, et al. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 2001; 69: 5121–5130
   PubMed Web of Science ®Google Scholar
• Holzhausen M, Spolidorio L C, Vergnolle N. Role of protease-activated receptor-2 in inflammation, and its possible implications as a putative mediator of periodontitis. Mem Inst Oswaldo Cruz 2005; 100(Suppl 1)177–180
   PubMedGoogle Scholar
• Steinhoff M, Vergnolle N, Young S, Tognetto M, Amadesi S, Ennes H, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000; 6: 151–158
   PubMed Web of Science ®Google Scholar
• Amadesi S, Nie J, Vergnolle N, Cottrell G S, Grady E F, Trevisani M, et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004; 24: 4300–4312
   PubMed Web of Science ®Google Scholar
• Amadesi S, Cottrell G S, Divino L, Chapman K, Grady E F, Bautista F, et al. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase C- (epsilon) and A-dependent mechanisms in rats and mice. J Physiol 2006; 575: 555–571
   PubMed Web of Science ®Google Scholar
• Caterina M J, Leffler A, Malmberg A B, Martin W J, Trafton J, Petersen-Zeitz K R, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288: 306–313
   PubMed Web of Science ®Google Scholar
• Grant A D, Cottrell G S, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 2007; 578: 715–733
   PubMed Web of Science ®Google Scholar
• Hoogerwerf W A, Zou L, Shenoy M, Sun D, Micci M A, Lee-Hellmich H, et al. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 2001; 21: 9036–9042
   PubMedGoogle Scholar
• Kayssi A, Amadesi S, Bautista F, Bunnett N W, Vanner S. Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon. J Physiol 2007; 580: 977–991
   PubMedGoogle Scholar
• Reed D E, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady E F, et al. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea pig submucosal neurons. J Physiol 2003; 547: 531–542
   PubMedGoogle Scholar
• de Garavilla L, Vergnolle N, Young S H, Ennes H, Steinhoff M, Ossovskaya V S, et al. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 2001; 133: 975–987
   PubMed Web of Science ®Google Scholar